Transcendental Meditation and Yoga: Short- and Long-term Effects in Cardiac Rehabilitation Patients - a Pilot Study
TMY_Rehab
1 other identifier
interventional
30
1 country
1
Brief Summary
Atherosclerotic cardiovascular disease (CVD) is the leading cause of death in Austria. The ESC guidelines recommend cardiac rehabilitation after coronary events (acute coronary syndrome, myocardial infarction, etc) with the highest level of evidence. Drug therapy and non-pharmacological measures such as a targeted and individualized exercise program, stress management programs, reduction of cardiovascular risk parameters through training, nutritional counseling, smoking cessation, etc. reduce the cardiovascular risk of recurrence. The reduction of psychosocial stress is regarded as one of the major factors in cardiac rehabilitation, alongside physical training and nutrition. In this study, transcendental meditation (TM) and yoga will be added on top of regular cardiac rehabilitation to investigate the efficiency of these methods to possibly improve the quality of life of recovering patients. Both methods are believed to reduce stress for users, while being relatively easy to introduce to and implement in daily life for beginners, carrying no extra cost for them further down the line. The main hypothesis is that cardiac patients undergoing rehabilitation plus TM or yoga therapy will show changes in endothelial function, micobiome and stress levels. Three groups of 10 participants from a cardiac cardiac rehabilitation will be subjected to standard rehabilitation, rehabilitation with meditation, and rehabilitation with yoga, respectively. The vascular state of each patient will be closely monitored over the 4 weeks, as well as after a 1-year follow up. Furthermore, the expected stress reductions will be assessed in short term and long-term by researching hair cortisol levels, on top of self-reporting questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cardiovascular-diseases
Started Oct 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedFirst Submitted
Initial submission to the registry
August 19, 2021
CompletedFirst Posted
Study publicly available on registry
September 5, 2021
CompletedSeptember 5, 2021
August 1, 2021
1 year
August 19, 2021
August 31, 2021
Conditions
Outcome Measures
Primary Outcomes (13)
Change of arterial Stiffness
Arterial Stiffness will be assessed using pulse wave velocity measurement via the vicorder device
through study completion, an average of 1 year
Change of Retinal Microvasculature
Will be assessed via retinal imaging
through study completion, an average of 1 year
Changes in heart rate to orthostatic loading
Patients will be asked to sit for 5 minutes and then stand up straight for 5 minutes. Changes in heart rate during this period will be assessed.
through study completion, an average of 1 year
Changes in blood pressure to orthostatic loading
Patients will be asked to sit for 5 minutes and then stand up straight for 5 minutes. Changes in blood pressure during this period will be assessed.
through study completion, an average of 1 year
Changes in Microbiome Samples
Stool samples will be collected to analyse the changes in the microbiome
through study completion, an average of 1 year
Change in stress levels via cortisol measurements from hair samples
Hair samples will be collected from the posterior vertex and cut as close to the scalp as possible and cut in pieces with 1 cm each. 1 cm equals 1 month of stress levels. A minimum of 10 mg of hair will be used for each sample.
through study completion, an average of 1 year
Changes in The Pittsburgh Sleep Quality Index (PSQI)
self-report questionnaire that assesses sleep quality over a 1-month time interval
through study completion, an average of 1 year
Changes in SF-36
SF-36 is a set of generic, coherent, and easily administered quality-of-life measures. These measures rely upon patient self-reporting and are now widely utilized by managed care organizations and by Medicare for routine monitoring and assessment of care outcomes in adult patients.
through study completion, an average of 1 year
Changes in POMS - short form
POMS measures six different dimensions of mood swings over a period of time. These include: Tension or Anxiety, Anger or Hostility, Vigor or Activity, Fatigue or Inertia, Depression or Dejection, Confusion or Bewilderment.
through study completion, an average of 1 year
Changes in PSQ20
The aim of the Perceived Stress Questionnaire is to identify and investigate the subjective perception, evaluation and further processing of stressors. This should also question the dominance and objectivity of external stressors.
through study completion, an average of 1 year
Changes in Spielberger State Trait Anxiety Inventory (STAI)
It consists of two parts (each 20 questions) rating the answers on a 4-point scale. The score for the global test may range between 40-160 points. It evaluates state anxiety (in a specific situation) or trait anxiety (as part of a person´s character).
through study completion, an average of 1 year
Changes in Tryptophan pathway
Tryptophan as stress marker from plasma samples
through study completion, an average of 1 year
Changes in Kynurenin levels
Kynurenin as stress marker from plasma samples
through study completion, an average of 1 year
Study Arms (3)
Control Goups
NO INTERVENTIONThe control group (A) receives standard exercise therapy that is part of the rehabilitation at the center and no additional intervention
Transcendental Meditation
EXPERIMENTALThe intervention group (B) receives transcendental meditation sessions (twice per day for 30 minutes) additionally to the standard rehabilitation therapy.
Yoga
EXPERIMENTALThe intervention group (C) receives yoga sessions (twice per day for 30 minutes) additionally to the standard rehabilitation therapy.
Interventions
In the beginning, the patients from group B will receive an introductory lecture about transcendental meditation (TM) which includes general information, the procedure itself and other techniques of relaxation and personal development. In this first session the method is learned by practice, in the following 3 meetings additional instructions are given about the correct practice of the TM technique; TM is practiced twice a day for 20 minutes. The method is easy to learn and effortless. To guarantee the right performance of TM by the patients, there will be two group meetings per week and one individual personal meeting with the TM teacher.After discharge from the rehabilitation program (after 4 weeks) there will be meetings offered according to the patients need. This will then be arranged individually.
In addition to the standard rehabilitation exercise training, the patients in this group will receive a 20-minute workshop where they learn how to do the yoga exercise. The initial yoga workshop will be held by Dr. Gilda Wüst who is a yoga expert with a lot of experience based in St. Radegund. After this, yoga sessions will be included (additionally to the regular/standard exercise) into their daily timetable. Two yoga sessions will be done every day, one in the morning (6:30-6:50) and one in the evening (16:30-16:50) and will last for about 20 minutes.
Eligibility Criteria
You may qualify if:
- Patients after myocardial infarction (MI)
- after ST-level myocardial infarction (STEMI) and
- non ST-level myocardial infarction (NSTEMI)
- after acute coronary syndrome (ACS)
- coronary artery disease (CAD) with percutaneous coronary intervention (PCI),
- after coronary artery bypass graft (CABG)
- age range 40-80
- admitted to the cardiac rehabilitatoin center in St. Radegund.
You may not qualify if:
- patients who must be monitored because of clinical symptoms (subjects with NYHA III, mini mental score more than 26, or subjects who are not sufficiently mobilized)
- subjects who regularly perform Yoga exercises or any other meditation techniques
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of Graz
Graz, Styria, 8036, Austria
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nandu Goswami, MD
nandu.goswami@medunigraz.at
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2021
First Posted
September 5, 2021
Study Start
October 1, 2019
Primary Completion
October 1, 2020
Study Completion
December 31, 2020
Last Updated
September 5, 2021
Record last verified: 2021-08